Abstract
Therapeutic neovascularization through cell transplantation has widely been investigated as a cure for ischemia. However, there are several limitations to this technique, including low survival rate of the therapeutic cells and inflammation at the transplanted sites. Polyethylene glycol (PEG)/hyaluronic acid (HA)-based cryogels are used to overcome these problems as they provide cell adhesion sites owing to their interconnected macroporous structure, which increases cell viability in combination with the cryogel’s intrinsic biocompatibility. Furthermore, vascular endothelial growth factor (VEGF) plays a significant role in pro-angiogenesis of endothelial cells (ECs) and it has been demonstrated that injection of VEGF-secreting cells could enhance neovascularization at the sites of injection. In the present study, we developed a PEG diacrylate (PEGDA)/glycidyl methacrylate-HA (GMHA)-based cryogel system seeded with VEGF-transfected human tonsil-derived mesenchymal stem cells to induce enhanced neovascularization in murine hind-limb ischemia. Addition of GMHA allowed the PEGDA cryogel to enhance cell metabolism, including attachment and proliferation. The secreted VEGF affected human umbilical vein endothelial cells by enhancing in vitro angiogenesis. Finally, our cell-seeded cryogel successfully facilitated regeneration of blood flow and damaged tissue in a hind-limb ischemia model.
Similar content being viewed by others
References
Ouriel, K. (2001) Peripheral arterial disease. Lancet. 358: 1257–1264.
Norgren, L., W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J. Vasc. Surg. 45: S5–S67.
Jude, E. B., I. Eleftheriadou, and N. Tentolouris (2010) Peripheral arterial disease in diabetes—a review. Diabet. Med. 27: 4–14.
Rajagopalan, S., E. R. Mohler 3rd, R. J. Lederman, F. O. Mendelsohn, J. F. Saucedo, C. K. Goldman, J. Blebea, J. Macko, P. D. Kessler, H. S. Rasmussen, and B. H. Annex (2003) Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease. Circulation. 108: 1933–1938.
Inampudi, C., E. Akintoye, T. Ando, and A. Briasoulis (2018) Angiogenesis in peripheral arterial disease. Curr. Opin. Pharmacol. 39: 60–67.
Cooke, J. P. and D. W. Losordo (2015) Modulating the vascular response to limb ischemia. Circ. Res. 116: 1561–1578.
Samura, M., T. Hosoyama, Y. Takeuchi, K. Ueno, N. Morikage, and K. Hamano (2017) Therapeutic strategies for cell-based neovascularization in critical limb ischemia. J. Transl. Med. 15: 49.
Mount, N. M., S. J. Ward, P. Kefalas, and J. Hyllner (2015) Cell-based therapy technology classifications and translational challenges. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 370: 20150017.
Manigandan, S. and J. W. Yun (2020) Urolithin A induces brown-like phenotype in 3T3-L1 white adipocytes via β3-adrenergic receptor-p38 MAPK signaling pathway. Biotechnol. Bioprocess Eng. 25: 345–355.
Tang, Y. L., Y. Tang, Y. C. Zhang, K. Qian, L. Shen, and M. I. Phillips (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J. Am. Coll. Cardiol. 46: 1339–1350.
Li, W., N. Ma, L. L. Ong, C. Nesselmann, C. Klopsch, Y. Ladilov, D. Furlani, C. Piechaczek, J. M. Moebius, K. Lützow, A. Lendlein, C. Stamm, R. K. Li, and G. Steinhoff (2007) Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells. 25: 2118–2127.
Hua, P., J. Liu, J. Tao, J. Liu, and S. Yang (2015) Influence of caspase-3 silencing on the proliferation and apoptosis of rat bone marrow mesenchymal stem cells under hypoxia. Int. J. Clin. Exp. Med. 8: 1624–1633.
Tsubokawa, T., K. Yagi, C. Nakanishi, M. Zuka, A. Nohara, H. Ino, N. Fujino, T. Konno, M. Kawashiri, H. Ishibashi-Ueda, N. Nagaya, and M. Yamagishi (2010) Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 298: H1320–H1329.
Henderson, T. M. A., K. Ladewig, D. N. Haylock, K. M. McLean, and A. J. O’Connor (2013) Cryogels for biomedical applications. J. Mater. Chem. B. 1: 2682–2695.
Göppert, B., T. Sollich, P. Abaffy, A. Cecilia, J. Heckmann, A. Neeb, A. Bäcker, T. Baumbach, F. J. Gruhl, and A. C. B. Cato (2016) Superporous poly(ethylene glycol) diacrylate cryogel with a defined elastic modulus for prostate cancer cell research. Small. 12: 3985–3994.
Rezaeeyazdi, M., T. Colombani, A. Memic, and A. S. Bencherif (2018) Injectable hyaluronic acid-co-gelatin cryogels for tissue-engineering applications. Materials. 11: 1374.
Han, M. E., S. H. Kim, H. D. Kim, H. G. Yim, S. A. Bencherif, T. I. Kim, and N. S. Hwang (2016) Extracellular matrix-based cryogels for cartilage tissue engineering. Int. J. Biol. Macromol. 93: 1410–1419.
Dong, R., X. Zhao, B. Guo, and P. X. Ma (2016) Self-healing conductive injectable hydrogels with antibacterial activity as cell delivery carrier for cardiac cell therapy. ACS Appl. Mater. Interfaces. 8: 17138–17150.
Kim, H. D., Y. Lee, Y. Kim, Y. Hwang, and N. S. Hwang (2017) Biomimetically reinforced polyvinyl alcohol-based hybrid scaffolds for cartilage tissue engineering. Polymers. 9: 655.
Mattheolabakis, G., L. Milane, A. Singh, and M. M. Amiji (2015) Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J. Drug Target. 23: 605–618.
Bhattacharya, D. S., D. Svechkarev, J. J. Souchek, T. K. Hill, M. A. Taylor, A. Natarajan, and A. M. Mohs (2017) Impact of structurally modifying hyaluronic acid on CD44 interaction. J. Mater. Chem B. 5: 8183–8192.
Basak, S. (2020) The age of multistimuli-responsive nanogels: The finest evolved nano delivery system in biomedical sciences. Biotechnol. Bioprocess Eng. 25: 655–669.
Kim, T. H., D. S. Yoo, and J. C. Kim (2019) In vitro dermal delivery of epidermal growth factor using redox-responsive cubosomes. Biotechnol. Bioprocess Eng. 24: 273–281.
Kim, G., Y. S. Park, Y. Lee, Y. M. Jin, D. H. Choi, K. H. Ryu, Y. J. Park, K. D. Park, and I. Jo (2018) Tonsil-derived mesenchymal stem cell-embedded in situ crosslinkable gelatin hydrogel therapy recovers postmenopausal osteoporosis through bone regeneration. PLoS One. 13: e0200111.
Matsumoto, R., T. Omura, M. Yoshiyama, T. Hayashi, S. Inamoto, K. R. Koh, K. Ohta, Y. Izumi, Y. Nakamura, K. Akioka, Y. Kitaura, K. Takeuchi, and J. Yoshikawa (2005) Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 25: 1168–1173.
Cho, H. M., P. H. Kim, H. K. Chang, Y. M. Shen, K. Bonsra, B. J. Kang, S. Y. Yum, J. H. Kim, S. Y. Lee, M. C. Choi, H. H. Kim, G. Jang, and J. Y. Cho (2017) Targeted genome engineering to control VEGF expression in human umbilical cord blood-derived mesenchymal stem cells: Potential implications for the treatment of myocardial infarction. Stem Cells Transl. Med. 6: 1040–1051.
Choi, Y. H., S. H. Kim, I. S. Kim, K. Kim, S. K. Kwon, and N. S. Hwang (2019) Gelatin-based micro-hydrogel carrying genetically engineered human endothelial cells for neovascularization. Acta Biomater. 95: 285–296.
Rajagopalan, S., E. Mohler 3rd, R. J. Lederman, J. Saucedo, F. O. Mendelsohn, J. Olin, J. Blebea, C. Goldman, J. D. Trachtenberg, M. Pressler, H. Rasmussen, B. H. Annex, and A. T. Hirsch (2003) Regional angiogenesis with vascular endothelial growth factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. Am. Heart J. 145: 1114–1118.
Nikol, S., I. Baumgartner, E. Van Belle, C. Diehm, A. Visona, M. C. Capogrossi, N. Ferreira-Maldent, A. Gallino, M. G. Wyatt, L. D. Wijesinghe, M. Fusari, D. Stephan, J. Emmerich, G. Pompilio, F. Vermassen, E. Pham, V. Grek, M. Coleman, and F. Meyer (2008) Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol. Ther. 16: 972–978.
Belch, J., W. R. Hiatt, I. Baumgartner, I. V. Driver, S. Nikol, L. Norgren, and E. Van Belle (2011) Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet. 377: 1929–1937.
Matyas, L., K. L. Schulte, J. A. Dormandy, L. Norgren, O. Sowade, G. Grotzbach, U. Palmer-Kazen, G. M. Rubanyi, and E. Wahlberg (2005) Arteriogenic gene therapy in patients with unreconstructable critical limb ischemia: a randomized, placebo-controlled clinical trial of adenovirus 5-delivered fibroblast growth factor-4. Hum. Gene. Ther. 16: 1202–1211.
Mukherjee, S., K. R. Aseer, and J. W. Yun (2020) Roles of macrophage colony stimulating factor in white and brown adipocytes. Biotechnol. Bioprocess Eng. 25: 29–38.
Taniyama, Y., R. Morishita, M. Aoki, H. Nakagami, K. Yamamoto, K. Yamazaki, K. Matsumoto, T. Nakamura, Y. Kaneda, and T. Ogihara (2001) Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene. Ther. 8: 181–189.
Powell, R. J., M. Simons, F. O. Mendelsohn, G. Daniel, T. D. Henry, M. Koga, R. Morishita, and B. H. Annex (2008) Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation. 118: 58–65.
Kibbe, M. R., A. T. Hirsch, F. O. Mendelsohn, M. G. Davies, H. Pham, J. Saucedo, W. Marston, W. B. Pyun, S. K. Min, B. G. Peterson, A. Comerota, D. Choi, J. Ballard, R. A. Bartow, D. W. Losordo, W. Sherman, V. Driver, and E. C. Perin (2016) Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia. Gene. Ther. 23: 306–312.
Gupta, K., S. Kshirsagar, W. Li, L. Gui, S. Ramakrishnan, P. Gupta, P. Y. Law, and R. P. Hebbel (1999) VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp. Cell Res. 247: 495–504.
Abid, M. R., S. Guo, T. Minami, K. C. Spokes, K. Ueki, C. Skurk, K. Walsh, and W. C. Aird (2004) Vascular endothelial growth factor activates PI3K/Akt/Forkhead signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 24: 294–300.
Karar, J. and A. Maity (2011) PI3K/AKT/mTOR pathway in angiogenesis. Front. Mol. Neurosci. 4: 51.
Kim, Y. G., U. Park, B. J. Park, and K. Kim (2019) Exosome-mediated bidirectional signaling between mesenchymal stem cells and chondrocytes for enhanced chondrogenesis. Biotechnol. Bioprocess Eng. 24: 734–744.
You, J. B., Y. Yoo, M. S. Oh, and S. G. Im (2014) Simple and reliable method to incorporate the Janus property onto arbitrary porous substrates. ACS Appl. Mater. Interfaces. 6: 4005–4010.
Hwang, Y., C. Zhang, and S. Varghese (2010) Poly(ethylene glycol) cryogels as potential cell scaffolds: effect of polymerization conditions on cryogel microstructure and properties. J. Mater. Chem. 20: 345–351.
Jeong, H., E. S. Lee, G. Jung, J. Park, B. Jeong, K. H. Ryu, N. S. Hwang, and H. Lee (2016) Bioreducible-cationic poly(amido amine)s for enhanced gene delivery and osteogenic differentiation of tonsil-derived mesenchymal stem cells. J. Biomed. Nanotechnol. 12: 1023–1034.
Choi, Y. H., S. C. Heo, Y. W. Kwon, H. D. Kim, S. H. L. Kim, I. H. Jang, J. H. Kim, and N. S. Hwang (2015) Injectable PLGA microspheres encapsulating WKYMVM peptide for neova-scularization. Acta Biomater. 25: 76–85.
Choi, Y. H., S. H. Kim, I. G. Kim, J. H. Lee, and S. K. Kwon (2019) Injectable basic fibroblast growth factor-loaded alginate/hyaluronic acid hydrogel for rejuvenation of geriatric larynx. Acta Biomater. 89: 104–114.
Memic, A., T. Colombani, L. J. Eggermont, M. Rezaeeyazdi, J. Steingold, Z. J. Rogers, K. J. Navare, H. S. Mohammed, and S. A. Bencherif (2019) Latest advances in cryogel technology for biomedical applications. Adv. Therap. 2: 1800114.
Chang, K. H., H. T. Liao, and J. P. Chen (2013) Preparation and characterization of gelatin/hyaluronic acid cryogels for adipose tissue engineering: in vitro and in vivo studies. Acta Biomater. 9: 9012–9026.
Kim, B. S. and D. J. Mooney (1998) Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. 16: 224–230.
Baxamusa, S. H., S. G. Im, and K. K. Gleason (2009) Initiated and oxidative chemical vapor deposition: a scalable method for conformal and functional polymer films on real substrates. Phys. Chem. Chem. Phys. 11: 5227–5240.
Yu, S. J., K. Pak, M. J. Kwak, M. Joo, B. J. Kim, M. S. Oh, J. Baek, H. Park, G. Choi, D. H. Kim, J. Choi, Y. Choi, J. Shin, H. Moon, E. Lee, and S. G. Im (2018) Initiated chemical vapor deposition: A versatile tool for various device applications. Adv. Eng. Mater. 20: 1700622.
Tsibouklis, J., P. Graham, P. J. Eaton, J. R. Smith, T. G. Nevell, J. D. Smart, and R. J. Ewen (2000) Poly(perfluoroalkyl methacrylate) film structures: Surface organization phenomena, surface energy determinations, and force of adhesion measurements. Macromolecules. 33: 8460–8465.
Lee, H. S., H. Kim, J. H. Lee, and J. B. Kwak (2019) Fabrication of a conjugated fluoropolymer film using one-step iCVD process and its mechanical durability. Coatings. 9: 430.
Lafuma, A. and D. Quéré (2003) Superhydrophobic states. Nat. Mater. 2: 457–460.
Yoo, Y., J. B. You, W. Choi, and S. G. Im (2013) A stacked polymer film for robust superhydrophobic fabrics. Polym. Chem. 4: 1664–1671.
Youngblood, J. P. and N. R. Sottos (2008) Bioinspired materials for self-cleaning and self-healing. MRS Bulletin. 33: 732–741.
Lin, C. C. and K. S. Anseth (2009) PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm. Res. 26: 631–643.
Parlato, M., S. Reichert, N. Barney, and W. L. Murphy (2014) Poly(ethylene glycol) hydrogels with adaptable mechanical and degradation properties for use in biomedical applications. Macromol. Biosci. 14: 687–698.
Jia, X. and K. L. Kiick (2009) Hybrid multicomponent hydrogels for tissue engineering. Macromol. Biosci. 9: 140–156.
Lee, H. J., A. Sen, S. Bae, J. S. Lee, and K. Webb (2015) Poly(ethylene glycol) diacrylate/hyaluronic acid semi-interpenetrating network compositions for 3-D cell spreading and migration. Acta Biomater. 14: 43–52.
Connors, R. C., J. J. Muir, Y. Liu, G. R. Reiss, P. C. Kouretas, M. G. Whitten, T. K. Sorenson, G. D. Prestwich, and D. A. Bull (2007) Postoperative pericardial adhesion prevention using Carbylan-SX in a rabbit model. J. Surg. Res. 140: 237–242.
Zheng Shu, X., Y. Liu, F. S. Palumbo, Y. Luo, and G. D. Prestwich (2004) In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials. 25: 1339–1348.
Burdick, J. A. and G. D. Prestwich (2011) Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 23: H41–H56.
Solis, M. A., Y. H. Chen, T. Y. Wong, V. Z. Bittencourt, Y. C. Lin, and L. L. H. Huang (2012) Hyaluronan regulates cell behavior: A potential niche matrix for stem cells. Biochem. Res. Int. 2012: 346972.
Lam, J., N. F. Truong, and T. Segura (2014) Design of cell-matrix interactions in hyaluronic acid hydrogel scaffolds. Acta Biomater. 10: 1571–1580.
Lee, B. J., D. W. Kang, H. Y. Park, J. S. Song, J. M. Kim, J. Y. Jang, J. C. Lee, S. G. Wang, J. S. Jung, and S. C. Shin (2016) Isolation and localization of mesenchymal stem cells in human palatine tonsil by W5C5 (SUSD2). Cell. Physiol. Biochem. 38: 83–93.
Oh, S. Y., Y. M. Choi, H. Y. Kim, Y. S. Park, S. C. Jung, J. W. Park, S. Y. Woo, K. H. Ryu, H. S. Kim, and I. Jo (2019) Application of tonsil-derived mesenchymal stem cells in tissue regeneration: Concise review. Stem Cells. 37: 1252–1260.
Shin, S. C., Y. Seo, H. Y. Park, D. W. Jung, T. H. Shin, H. Son, Y. K. Kim, J. C. Lee, E. S. Sung, J. Y. Jang, H. S. Kim, and B. J. Lee (2018) Regenerative potential of tonsil mesenchymal stem cells on surgical cutaneous defect. Cell Death Dis. 9: 183.
Koh, R. H., Y. Jin, B. J. Kang, and N. S. Hwang (2017) Chondrogenically primed tonsil-derived mesenchymal stem cells encapsulated in riboflavin-induced photocrosslinking collagen-hyaluronic acid hydrogel for meniscus tissue repairs. Acta Biomater. 53: 318–328.
Park, S., Y. Choi, N. Jung, Y. Yu, K. H. Ryu, H. S. Kim, I. Jo, B. O. Choi, and S. C. Jung (2016) Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration. Int. J. Mol. Med. 37: 1209–1220.
Enis, D. R., B. R. Shepherd, Y. Wang, A. Qasim, C. M. Shanahan, P. L. Weissberg, M. Kashgarian, J. S. Pober, and J. S. Schechner (2005) Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc. Natl. Acad. Sci. USA. 102: 425–430.
Ye, L., H. K. Haider, R. Tan, W. Toh, P. K. Law, W. Tan, L. Su, W. Zhang, R. Ge, Y. Zhang, Y. Lim, and E. K. W. Sim (2007) Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation. 116: I113–I120.
Cho, S. W., F. Yang, S. M. Son, H. J. Park, J. J. Green, S. Bogatyrev, Y. Mei, S. Park, R. Langer, and D. G. Anderson (2012) Therapeutic angiogenesis using genetically engineered human endothelial cells. J. Control. Release. 160: 515–524.
Yang, F., S. W. Cho, S. M. Son, S. R. Bogatyrev, D. Singh, J. J. Green, Y. Mei, S. Park, S. H. Bhang, B. S. Kim, R. Langer, and D. G. Anderson (2010) Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc. Natl. Acad. Sci. U S A. 107: 3317–3322.
Carmeliet, P. (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology. 69 Suppl 3: 4–10.
Zhao, X., J. Kim, C. A. Cezar, N. Huebsch, K. Lee, K. Bouhadir, and D. J. Mooney (2011) Active scaffolds for on-demand drug and cell delivery. Proc. Natl. Acad. Sci. U S A. 108: 67–72.
Drury, J. L. and D. J. Mooney (2003) Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 24: 4337–4351.
Costa, A. M. S., M. Alatorre-Meda, C. Alvarez-Lorenzo, and J. F. Mano (2015) Superhydrophobic surfaces as a tool for the fabrication of hierarchical spherical polymeric carriers. Small. 11: 3648–3652.
Acknowledgements
This research was supported by the Korea Health Industry Development Institute (KHIDI-HI19C1352), by the National Research Foundation (NRF-2021R1A2C2008821, NRF-2021M3E5E5096460, and NRF-2019R1I1A1A01059554), and by the Ministry of Trade, Industry and Energy (MOTIE-20016553), through funded by the Korea government. The Institute of Engineering Research at Seoul National University provided research facilities for this work.
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
All surgery procedures were approved by the Seoul National University Animal Care Committee (protocol #SNU-130226-2).
Informed consent was obtained from the patients at the Department of Otorhinolaryngology Head and Neck Surgery, Seoul National University Hospital (Seoul, Korea).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Sun, W., Choi, J.H., Choi, Y.H. et al. VEGF-overexpressed Human Tonsil-derived Mesenchymal Stem Cells with PEG/HA-based Cryogels for Therapeutic Angiogenesis. Biotechnol Bioproc E 27, 17–29 (2022). https://doi.org/10.1007/s12257-021-0061-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-021-0061-x